(Q35649437)

9 August 2017

1 reference

title

Treatment of PCOS with metformin and other insulin-sensitizing agents (English)

1 reference

9 August 2017

1 reference

Emre Seli

1

1 reference

9 August 2017

Antoni J Duleba

series ordinal

2

1 reference

9 August 2017

publication date

1 February 2004

1 reference

9 August 2017

published in

Current diabetes report

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

69-75

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-004-0014-8

9 August 2017

exact match

0 references

cites work

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0014-8

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0014-8

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0014-8

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0014-8

Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0014-8

Hepatocellular injury in a patient receiving pioglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0014-8

Influence of past reproductive performance on risk of spontaneous abortion

21 January 2018

1 reference

12 December 2020

Hemostatic and metabolic variables in women with polycystic ovary syndrome

1 reference

12 December 2020

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

12 December 2020

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

1 reference

12 December 2020

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

1 reference

12 December 2020

Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.

1 reference

12 December 2020

Differentiating members of the thiazolidinedione class: a focus on safety

1 reference

12 December 2020

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

1 reference

12 December 2020

Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones

1 reference

12 December 2020

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial

1 reference

12 December 2020

Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche

1 reference

12 December 2020

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years

1 reference

12 December 2020

Prospective analysis of the insulin-resistance syndrome (syndrome X).

1 reference

12 December 2020

Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

1 reference

12 December 2020

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

12 December 2020

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

1 reference

12 December 2020

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

1 reference

12 December 2020

Low grade chronic inflammation in women with polycystic ovarian syndrome

1 reference

12 December 2020

Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.

1 reference

12 December 2020

Diabetes prevalence and risk factors in polycystic ovary syndrome

1 reference

12 December 2020

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women

1 reference

12 December 2020

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

1 reference

12 December 2020

High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome

1 reference

12 December 2020

Insulin actions on ovarian steroidogenesis are not modulated by metformin

1 reference

12 December 2020

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

1 reference

12 December 2020

Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys.

1 reference

12 December 2020

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

1 reference

12 December 2020

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

1 reference

12 December 2020

Metformin directly inhibits androgen production in human thecal cells

1 reference

12 December 2020

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

1 reference

12 December 2020

Oral hypoglycaemics in the first trimester and fetal outcome

1 reference

12 December 2020

Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group

1 reference

12 December 2020

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

1 reference

12 December 2020

Can metformin reduce insulin resistance in polycystic ovary syndrome?

1 reference

12 December 2020

chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects

1 reference

12 December 2020

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

1 reference

12 December 2020

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

1 reference

12 December 2020

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome

1 reference

12 December 2020

Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity

1 reference

12 December 2020

Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism

1 reference

12 December 2020

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

1 reference

12 December 2020

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

1 reference

12 December 2020

Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial

1 reference

12 December 2020

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies

1 reference

12 December 2020

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

1 reference

12 December 2020

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

12 December 2020

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

1 reference

12 December 2020

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

1 reference

12 December 2020

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

12 December 2020

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

12 December 2020

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

12 December 2020

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

1 reference

12 December 2020

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

1 reference

12 December 2020

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

1 reference

12 December 2020

Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens

1 reference

12 December 2020

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

12 December 2020

10.1007/S11892-004-0014-8

Identifiers

DOI

1 reference

release_ugxpuszsmfdrhlamflljt6qjr4

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugxpuszsmfdrhlamflljt6qjr4

24 November 2022

mapped directly with Wikidata item

1 reference